Auxier Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.23M Buy
68,911
+6,375
+10% +$585K 0.89% 38
2025
Q4
$5.62M Sell
62,536
-842
-1% -$79.8K 0.79% 40
2025
Q3
$6.24M Sell
63,378
-350
-0.5% -$34.7K 0.87% 36
2025
Q2
$5.81M Sell
63,728
-271
-0.4% -$26.2K 0.85% 38
2025
Q1
$7.24M Sell
63,999
-55
-0.1% -$5.88K 1.08% 30
2024
Q4
$6.77M Buy
64,054
+481
+0.8% +$51.6K 1.05% 31
2024
Q3
$6.86M Buy
63,573
+2,070
+3% +$226K 1.01% 31
2024
Q2
$6.67M Buy
61,503
+543
+0.9% +$64K 1.06% 30
2024
Q1
$8.05M Sell
60,960
-435
-0.7% -$54.3K 1.22% 26
2023
Q4
$7.47M Sell
61,395
-344
-0.6% -$38.4K 1.21% 26
2023
Q3
$6.93M Sell
61,739
-120
-0.2% -$15.2K 1.18% 27
2023
Q2
$9.01M Hold
61,859
1.49% 16
2023
Q1
$7.99M Sell
61,859
-150
-0.2% -$18.8K 1.38% 20
2022
Q4
$7.91M Sell
62,009
-25
-0% -$2.9K 1.36% 20
2022
Q3
$6.49M Sell
62,034
-30
-0% -$3.29K 1.25% 25
2022
Q2
$6.52M Hold
62,064
1.16% 23
2022
Q1
$7.94M Sell
62,064
-858
-1% -$103K 1.26% 21
2021
Q4
$7.76M Sell
62,922
-154
-0.2% -$20.2K 1.2% 20
2021
Q3
$8.96M Sell
63,076
-77
-0.1% -$11.3K 1.52% 18
2021
Q2
$9.86M Sell
63,153
-691
-1% -$112K 1.63% 15
2021
Q1
$9.92M Sell
63,844
-6,880
-10% -$1.07M 1.71% 14
2020
Q4
$10.6M Sell
70,724
-1,220
-2% -$172K 1.96% 10
2020
Q3
$9.51M Sell
71,944
-114
-0.2% -$14.9K 1.99% 11
2020
Q2
$8.35M Sell
72,058
-82
-0.1% -$9.45K 1.84% 13
2020
Q1
$7.08M Sell
72,140
-505
-0.7% -$66.2K 1.77% 15
2019
Q4
$10.6M Sell
72,645
-129
-0.2% -$17.8K 1.97% 13
2019
Q3
$9.7M Sell
72,774
-13,817
-16% -$1.78M 1.95% 13
2019
Q2
$9.9M Sell
86,591
-1,257
-1% -$147K 1.97% 12
2019
Q1
$10.9M Sell
87,848
-1,184
-1% -$135K 2.24% 10
2018
Q4
$8.96M Sell
89,032
-36
-0% -$4.05K 2% 13
2018
Q3
$11.4M Sell
89,068
-186
-0.2% -$22.1K 2.14% 11
2018
Q2
$9.66M Sell
89,254
-324
-0.4% -$35.3K 1.93% 13
2018
Q1
$9.48M Sell
89,578
-309
-0.3% -$35.9K 1.9% 14
2017
Q4
$10.5M Buy
89,887
+747
+0.8% +$84.5K 2.02% 11
2017
Q3
$10.1M Sell
89,140
-72
-0.1% -$8.31K 2.06% 9
2017
Q2
$11.1M Hold
89,212
2.27% 8
2017
Q1
$10.6M Buy
89,212
+103
+0.1% +$11.7K 2.22% 9
2016
Q4
$8.93M Buy
89,109
+2,832
+3% +$304K 1.94% 13
2016
Q3
$10.9M Sell
86,277
-51
-0.1% -$6.3K 2.44% 10
2016
Q2
$10.1M Hold
86,328
2.31% 9
2016
Q1
$8.94M Sell
86,328
-155
-0.2% -$15K 2.12% 12
2015
Q4
$8.61M Sell
86,483
-4,944
-5% -$484K 1.95% 11
2015
Q3
$8.34M Sell
91,427
-2,163
-2% -$217K 1.95% 11
2015
Q2
$9.93M Buy
93,590
+103
+0.1% +$11.4K 2.07% 12
2015
Q1
$10.7M Sell
93,487
-2,243
-2% -$256K 2.15% 8
2014
Q4
$10.5M Sell
95,730
-335
-0.3% -$35.3K 2.1% 9
2014
Q3
$9.38M Sell
96,065
-155
-0.2% -$15.2K 1.95% 12
2014
Q2
$9.7M Sell
96,220
-2,173
-2% -$212K 1.98% 13
2014
Q1
$9.04M Sell
98,393
-2,343
-2% -$216K 1.92% 14
2013
Q4
$9.11M Sell
100,736
-52
-0.1% -$4.5K 1.92% 12
2013
Q3
$8.04M Hold
100,788
1.86% 17
2013
Q2
$7.33M Buy
+100,788
New +$7.54M 1.77% 19

Other funds holding ZBH

Auxier Asset Management's ZBH Position: Q1 2026 in Review

Auxier Asset Management increased its Zimmer Biomet (ZBH) stake by 10% in Q1 2026, buying an estimated $585K and bringing the position to 68,911 shares worth $6.23M. The position accounts for 0.89% of the portfolio, ranked #38.

Auxier Asset Management first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.4M in Q3 2018. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Auxier Asset Management held 68,911 shares of Zimmer Biomet worth $6.23M as of Q1 2026.
  • Auxier Asset Management bought 6,375 Zimmer Biomet shares in Q1 2026, an estimated $585K.
  • Zimmer Biomet made up 0.89% of Auxier Asset Management's portfolio in Q1 2026, its #38 holding.
  • Auxier Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Auxier Asset Management's Zimmer Biomet position peaked at $11.4M in Q3 2018.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Auxier Asset Management's 13F filing for Q1 2026, filed 14 May 2026.